Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Boris Draznin to Animals

This is a "connection" page, showing publications Boris Draznin has written about Animals.

 
Connection Strength
 
 
 
0.672
 
  1. Moriarty MW, McCurdy CE, Janssen RC, Shaw T, Leitner JW, Friedman JE, Draznin B. In vivo knockdown of p85alpha with an antisense oligonucleotide improves insulin sensitivity in Lep(ob/ob) and diet-induced obese mice. Horm Metab Res. 2009 Oct; 41(10):757-61.
    View in: PubMed
    Score: 0.018
  2. Kim T, Wayne Leitner J, Adochio R, Draznin B. Knockdown of JNK rescues 3T3-L1 adipocytes from insulin resistance induced by mitochondrial dysfunction. Biochem Biophys Res Commun. 2009 Jan 23; 378(4):772-6.
    View in: PubMed
    Score: 0.018
  3. Adochio R, Leitner JW, Hedlund R, Draznin B. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase. Endocrinology. 2009 Mar; 150(3):1165-73.
    View in: PubMed
    Score: 0.017
  4. Pereira RI, Leitner JW, Erickson C, Draznin B. Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase. Life Sci. 2008 Nov 07; 83(19-20):638-43.
    View in: PubMed
    Score: 0.017
  5. Nadeau KJ, Ehlers LB, Aguirre LE, Reusch JE, Draznin B. Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone. Diabetes Obes Metab. 2007 Sep; 9(5):714-23.
    View in: PubMed
    Score: 0.016
  6. Wang CC, Sorribas V, Sharma G, Levi M, Draznin B. Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis. 2007 Nov; 195(1):e65-75.
    View in: PubMed
    Score: 0.016
  7. Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes. 2006 Aug; 55(8):2392-7.
    View in: PubMed
    Score: 0.015
  8. Wang CC, Sharma G, Draznin B. Early growth response gene-1 expression in vascular smooth muscle cells effects of insulin and oxidant stress. Am J Hypertens. 2006 Apr; 19(4):366-72.
    View in: PubMed
    Score: 0.015
  9. Nadeau KJ, Ehlers LB, Aguirre LE, Moore RL, Jew KN, Ortmeyer HK, Hansen BC, Reusch JE, Draznin B. Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle. Am J Physiol Endocrinol Metab. 2006 Jul; 291(1):E90-8.
    View in: PubMed
    Score: 0.014
  10. Pereira RI, Draznin B. Inhibition of the phosphatidylinositol 3'-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes. Metabolism. 2005 Dec; 54(12):1636-43.
    View in: PubMed
    Score: 0.014
  11. Barbour LA, Mizanoor Rahman S, Gurevich I, Leitner JW, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdy CE, Yakar S, Leroith D, Kahn CR, Cantley LC, Friedman JE, Draznin B. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem. 2005 Nov 11; 280(45):37489-94.
    View in: PubMed
    Score: 0.014
  12. Wang CC, Goalstone ML, Draznin B. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes. 2004 Nov; 53(11):2735-40.
    View in: PubMed
    Score: 0.013
  13. Nadeau KJ, Leitner JW, Gurerich I, Draznin B. Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes. J Biol Chem. 2004 Aug 13; 279(33):34380-7.
    View in: PubMed
    Score: 0.013
  14. Barbour LA, Shao J, Qiao L, Leitner W, Anderson M, Friedman JE, Draznin B. Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocrinology. 2004 Mar; 145(3):1144-50.
    View in: PubMed
    Score: 0.012
  15. Wang CC, Gurevich I, Draznin B. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes. 2003 Oct; 52(10):2562-9.
    View in: PubMed
    Score: 0.012
  16. Golovchenko I, Yang CH, Goalstone ML, Draznin B. Garlic extract methylallyl thiosulfinate blocks insulin potentiation of platelet-derived growth factor-stimulated migration of vascular smooth muscle cells. Metabolism. 2003 Feb; 52(2):254-9.
    View in: PubMed
    Score: 0.012
  17. Stephens E, Thureen PJ, Goalstone ML, Anderson MS, Leitner JW, Hay WW, Draznin B. Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues. Am J Physiol Endocrinol Metab. 2001 Aug; 281(2):E217-23.
    View in: PubMed
    Score: 0.011
  18. Klemm DJ, Leitner JW, Watson P, Nesterova A, Reusch JE, Goalstone ML, Draznin B. Insulin-induced adipocyte differentiation. Activation of CREB rescues adipogenesis from the arrest caused by inhibition of prenylation. J Biol Chem. 2001 Jul 27; 276(30):28430-5.
    View in: PubMed
    Score: 0.010
  19. Goalstone ML, Leitner JW, Berhanu P, Sharma PM, Olefsky JM, Draznin B. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling. J Biol Chem. 2001 Apr 20; 276(16):12805-12.
    View in: PubMed
    Score: 0.010
  20. Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B. Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ Res. 2000 Oct 27; 87(9):746-52.
    View in: PubMed
    Score: 0.010
  21. Draznin B, Miles P, Kruszynska Y, Olefsky J, Friedman J, Golovchenko I, Stjernholm R, Wall K, Reitman M, Accili D, Cooksey R, McClain D, Goalstone M. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. Endocrinology. 2000 Apr; 141(4):1310-6.
    View in: PubMed
    Score: 0.010
  22. Goalstone ML, Wall K, Leitner JW, Kurowski T, Ruderman N, Pan SJ, Ivy JL, Moller DE, Draznin B. Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals. Diabetologia. 1999 Mar; 42(3):310-6.
    View in: PubMed
    Score: 0.009
  23. Goalstone ML, Leitner JW, Golovchenko I, Stjernholm MR, Cormont M, Le Marchand-Brustel Y, Draznin B. Insulin promotes phosphorylation and activation of geranylgeranyltransferase II. Studies with geranylgeranylation of rab-3 and rab-4. J Biol Chem. 1999 Jan 29; 274(5):2880-4.
    View in: PubMed
    Score: 0.009
  24. Goalstone ML, Draznin B. Effect of insulin on farnesyltransferase gene transcription and mRNA stability. Biochem Biophys Res Commun. 1999 Jan 08; 254(1):243-7.
    View in: PubMed
    Score: 0.009
  25. Goalstone ML, Natarajan R, Standley PR, Walsh MF, Leitner JW, Carel K, Scott S, Nadler J, Sowers JR, Draznin B. Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology. 1998 Oct; 139(10):4067-72.
    View in: PubMed
    Score: 0.009
  26. Goalstone ML, Leitner JW, Wall K, Dolgonos L, Rother KI, Accili D, Draznin B. Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor. J Biol Chem. 1998 Sep 11; 273(37):23892-6.
    View in: PubMed
    Score: 0.009
  27. Goalstone ML, Draznin B. What does insulin do to Ras? Cell Signal. 1998 May; 10(5):297-301.
    View in: PubMed
    Score: 0.008
  28. Sowers JR, Draznin B. Insulin, cation metabolism and insulin resistance. J Basic Clin Physiol Pharmacol. 1998; 9(2-4):223-33.
    View in: PubMed
    Score: 0.008
  29. Goalstone M, Carel K, Leitner JW, Draznin B. Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway. Endocrinology. 1997 Dec; 138(12):5119-24.
    View in: PubMed
    Score: 0.008
  30. Goalstone M, Leitner JW, Draznin B. GTP loading of farnesylated p21Ras by insulin at the plasma membrane. Biochem Biophys Res Commun. 1997 Oct 09; 239(1):42-5.
    View in: PubMed
    Score: 0.008
  31. Leitner JW, Kline T, Carel K, Goalstone M, Draznin B. Hyperinsulinemia potentiates activation of p21Ras by growth factors. Endocrinology. 1997 May; 138(5):2211-4.
    View in: PubMed
    Score: 0.008
  32. Carel K, Kummer JL, Schubert C, Leitner W, Heidenreich KA, Draznin B. Insulin stimulates mitogen-activated protein kinase by a Ras-independent pathway in 3T3-L1 adipocytes. J Biol Chem. 1996 Nov 29; 271(48):30625-30.
    View in: PubMed
    Score: 0.008
  33. Goalstone ML, Draznin B. Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes. J Biol Chem. 1996 Nov 01; 271(44):27585-9.
    View in: PubMed
    Score: 0.008
  34. Draznin B. Insulin signaling network -- waiting for Copernicus. Endocrinology. 1996 Jul; 137(7):2647-8.
    View in: PubMed
    Score: 0.007
  35. Schubert C, Carel K, DePaolo D, Leitner W, Draznin B. Interactions of protein kinase C with insulin signaling. Influence on GAP and Sos activities. J Biol Chem. 1996 Jun 28; 271(26):15311-4.
    View in: PubMed
    Score: 0.007
  36. Carel K, DePaolo D, Reusch JE, Leitner JW, Draznin B. Reduced phosphorylation of mitogen-activated protein kinase kinase in response to insulin in cells with truncated C-terminal domain of insulin receptor. Endocrinology. 1996 Jun; 137(6):2362-6.
    View in: PubMed
    Score: 0.007
  37. DePaolo D, Reusch JE, Carel K, Bhuripanyo P, Leitner JW, Draznin B. Functional interactions of phosphatidylinositol 3-kinase with GTPase-activating protein in 3T3-L1 adipocytes. Mol Cell Biol. 1996 Apr; 16(4):1450-7.
    View in: PubMed
    Score: 0.007
  38. Reusch JE, Hsieh P, Bhuripanyo P, Carel K, Leitner JW, Olefsky JM, Draznin B. Insulin inhibits nuclear phosphatase activity: requirement for the C-terminal domain of the insulin receptor. Endocrinology. 1995 Jun; 136(6):2464-9.
    View in: PubMed
    Score: 0.007
  39. Reusch JE, Bhuripanyo P, Carel K, Leitner JW, Hsieh P, DePaolo D, Draznin B. Differential requirement for p21ras activation in the metabolic signaling by insulin. J Biol Chem. 1995 Feb 03; 270(5):2036-40.
    View in: PubMed
    Score: 0.007
  40. Langlois WJ, Medh J, Leitner JW, Sasaoka T, Olefsky JM, Draznin B. Insulin and epidermal growth factor influence guanine nucleotide-releasing factor by distinct mechanisms. Endocrinology. 1994 Dec; 135(6):2412-7.
    View in: PubMed
    Score: 0.007
  41. Reusch JE, Hsieh P, Klemm D, Hoeffler J, Draznin B. Insulin inhibits dephosphorylation of adenosine 3',5'-monophosphate response element-binding protein/activating transcription factor-1: effect on nuclear phosphoserine phosphatase-2a. Endocrinology. 1994 Dec; 135(6):2418-22.
    View in: PubMed
    Score: 0.007
  42. Draznin B, Chang L, Leitner JW, Takata Y, Olefsky JM. Insulin activates p21Ras and guanine nucleotide releasing factor in cells expressing wild type and mutant insulin receptors. J Biol Chem. 1993 Sep 25; 268(27):19998-20001.
    View in: PubMed
    Score: 0.006
  43. Draznin B. Cytosolic calcium and insulin resistance. Am J Kidney Dis. 1993 Jun; 21(6 Suppl 3):32-8.
    View in: PubMed
    Score: 0.006
  44. Begum N, Olefsky JM, Draznin B. Mechanism of impaired metabolic signaling by a truncated human insulin receptor. Decreased activation of protein phosphatase 1 by insulin. J Biol Chem. 1993 Apr 15; 268(11):7917-22.
    View in: PubMed
    Score: 0.006
  45. Low Wang CC, Lu L, Leitner JW, Sarraf M, Gianani R, Draznin B, Greyson CR, Reusch JE, Schwartz GG. Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome. J Diabetes Complications. 2013 Jul-Aug; 27(4):307-15.
    View in: PubMed
    Score: 0.006
  46. Begum N, Leitner W, Reusch JE, Sussman KE, Draznin B. GLUT-4 phosphorylation and its intrinsic activity. Mechanism of Ca(2+)-induced inhibition of insulin-stimulated glucose transport. J Biol Chem. 1993 Feb 15; 268(5):3352-6.
    View in: PubMed
    Score: 0.006
  47. Reusch JE, Sussman KE, Draznin B. Inverse relationship between GLUT-4 phosphorylation and its intrinsic activity. J Biol Chem. 1993 Feb 15; 268(5):3348-51.
    View in: PubMed
    Score: 0.006
  48. Begum N, Draznin B. Effect of streptozotocin-induced diabetes on GLUT-4 phosphorylation in rat adipocytes. J Clin Invest. 1992 Oct; 90(4):1254-62.
    View in: PubMed
    Score: 0.006
  49. Begum N, Sussman KE, Draznin B. Calcium-induced inhibition of phosphoserine phosphatase in insulin target cells is mediated by the phosphorylation and activation of inhibitor 1. J Biol Chem. 1992 Mar 25; 267(9):5959-63.
    View in: PubMed
    Score: 0.006
  50. Begum N, Graham AL, Sussman KE, Draznin B. Role of cAMP in mediating effects of fasting on dephosphorylation of insulin receptor. Am J Physiol. 1992 Feb; 262(2 Pt 1):E142-9.
    View in: PubMed
    Score: 0.005
  51. Nishida K, Ohara T, Johnson J, Wallner JS, Wilk J, Sherman N, Kawakami K, Sussman KE, Draznin B. Na+/K(+)-ATPase activity and its alpha II subunit gene expression in rat skeletal muscle: influence of diabetes, fasting, and refeeding. Metabolism. 1992 Jan; 41(1):56-63.
    View in: PubMed
    Score: 0.005
  52. Metz S, Holmes D, Robertson RP, Leitner W, Draznin B. Gene expression of type I phospholipase A2 in pancreatic beta cells. Regulation of mRNA levels by starvation or glucose excess. FEBS Lett. 1991 Dec 16; 295(1-3):110-2.
    View in: PubMed
    Score: 0.005
  53. Reusch JE, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology. 1991 Dec; 129(6):3269-73.
    View in: PubMed
    Score: 0.005
  54. Begum N, Sussman KE, Draznin B. Differential effects of diabetes on adipocyte and liver phosphotyrosine and phosphoserine phosphatase activities. Diabetes. 1991 Dec; 40(12):1620-9.
    View in: PubMed
    Score: 0.005
  55. Ohara T, Sussman KE, Draznin B. Effect of diabetes on cytosolic free Ca2+ and Na(+)-K(+)-ATPase in rat aorta. Diabetes. 1991 Nov; 40(11):1560-3.
    View in: PubMed
    Score: 0.005
  56. Begum N, Sussman KE, Draznin B. High levels of cytosolic free calcium inhibit dephosphorylation of insulin receptor and glycogen synthase. Cell Calcium. 1991 Jun; 12(6):423-30.
    View in: PubMed
    Score: 0.005
  57. Lee J, Xu Y, Lu L, Bergman B, Leitner JW, Greyson C, Draznin B, Schwartz GG. Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity. Am J Physiol Heart Circ Physiol. 2010 Feb; 298(2):H310-9.
    View in: PubMed
    Score: 0.005
  58. Draznin B, Lewis D, Houlder N, Sherman N, Adamo M, Garvey WT, LeRoith D, Sussman K. Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. Endocrinology. 1989 Nov; 125(5):2341-9.
    View in: PubMed
    Score: 0.005
  59. Wang Y, Goodman M, Lumerman J, Sussman KE, Dahl R, Lafferty KJ, Draznin B. In vivo administration of interleukin-1 inhibits glucose-stimulated insulin release. Diabetes Res Clin Pract. 1989 Sep 18; 7(3):205-11.
    View in: PubMed
    Score: 0.005
  60. Draznin B. Intracellular calcium, insulin secretion, and action. Am J Med. 1988 Nov 28; 85(5A):44-58.
    View in: PubMed
    Score: 0.004
  61. Draznin B, Metz SA, Sussman KE, Leitner JW. Cyclosporin-induced inhibition of insulin release. Possible role of voltage-dependent calcium transport channels. Biochem Pharmacol. 1988 Oct 15; 37(20):3941-5.
    View in: PubMed
    Score: 0.004
  62. Draznin B, Leitner JW, Sussman KE, Sherman NA. Insulin and glucose modulate protein kinase C activity in rat adipocytes. Biochem Biophys Res Commun. 1988 Oct 14; 156(1):570-5.
    View in: PubMed
    Score: 0.004
  63. Draznin B, Sussman KE, Leitner JW, Metz SA. Glyburide increases cytosolic-free calcium concentrations in normal rat pancreatic islet cells. Metabolism. 1988 Jul; 37(7):660-3.
    View in: PubMed
    Score: 0.004
  64. Draznin B, Sussman KE, Kao M, Sherman N. Relationship between cytosolic free calcium concentration and 2-deoxyglucose uptake in adipocytes isolated from 2- and 12-month-old rats. Endocrinology. 1988 Jun; 122(6):2578-83.
    View in: PubMed
    Score: 0.004
  65. Draznin B, Dahl R, Sherman N, Sussman KE, Staehelin LA. Exocytosis in normal anterior pituitary cells. Quantitative correlation between growth hormone release and the morphological features of exocytosis. J Clin Invest. 1988 Apr; 81(4):1042-50.
    View in: PubMed
    Score: 0.004
  66. Draznin B, Sussman K, Kao M, Lewis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem. 1987 Oct 25; 262(30):14385-8.
    View in: PubMed
    Score: 0.004
  67. Draznin B, Metz SA, Sussman KE, Leitner JW. Measurement of cytosolic free calcium concentration in relation to insulin release in normal rat pancreatic islets. Diabetes Res Clin Pract. 1987 Sep-Oct; 3(5):291-5.
    View in: PubMed
    Score: 0.004
  68. Sussman KE, Leitner JW, Draznin B. Cytosolic free-calcium concentrations in normal pancreatic islet cells. Effect of secretagogues and somatostatin. Diabetes. 1987 May; 36(5):571-7.
    View in: PubMed
    Score: 0.004
  69. del Rincon JP, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, Barbour LA, Kopchick JJ, Friedman JE, Draznin B, Thorner MO. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes. 2007 Jun; 56(6):1638-46.
    View in: PubMed
    Score: 0.004
  70. Draznin B, Kao M, Sussman KE. Insulin and glyburide increase cytosolic free-Ca2+ concentration in isolated rat adipocytes. Diabetes. 1987 Feb; 36(2):174-8.
    View in: PubMed
    Score: 0.004
  71. Draznin B, Steiner C, Sherman N, Sussman K. Somatostatin inhibits fusion of pituitary secretion vesicles with the plasma membranes. Biochem Biophys Res Commun. 1986 Sep 14; 139(2):673-8.
    View in: PubMed
    Score: 0.004
  72. Goodman M, Leitner JW, Sussman KE, Draznin B. Insulin secretion in aging: studies with sequential gating of secretion vesicle margination and lysis. Endocrinology. 1986 Aug; 119(2):827-32.
    View in: PubMed
    Score: 0.004
  73. Draznin B, Goodman M, Leitner JW, Sussman KE. Feedback inhibition of insulin on insulin secretion in isolated pancreatic islets. Endocrinology. 1986 Mar; 118(3):1054-8.
    View in: PubMed
    Score: 0.004
  74. Trowbridge M, Draznin B. Insulin internalization and intracellular protein degradation: a quantitative correlation. Horm Metab Res. 1986 Mar; 18(3):156-8.
    View in: PubMed
    Score: 0.004
  75. Steiner C, Dahl R, Sherman N, Trowbridge M, Vatter A, Robbins R, Draznin B. Somatostatin receptors are biologically active before they are inserted into the plasma membrane. Endocrinology. 1986 Feb; 118(2):766-72.
    View in: PubMed
    Score: 0.004
  76. Draznin B, Steinberg JP, Leitner JW, Sussman KE. The nature of insulin secretory defect in aging rats. Diabetes. 1985 Nov; 34(11):1168-73.
    View in: PubMed
    Score: 0.004
  77. Draznin B, Sherman N, Sussman K, Dahl R, Vatter A. Internalization and cellular processing of somatostatin in primary culture of rat anterior pituitary cells. Endocrinology. 1985 Sep; 117(3):960-6.
    View in: PubMed
    Score: 0.004
  78. Draznin B, Leitner JW, Sussman KE. A unique control mechanism in the regulation of insulin secretion. Secretagogue-induced somatostatin receptor recruitment. J Clin Invest. 1985 May; 75(5):1510-6.
    View in: PubMed
    Score: 0.003
  79. Draznin B, Steinberg JP, Goodman M, Leitner JW, Sussman KE. Control of secretion vesicle margination and lysis by glucose, IBMX, and glyburide. Am J Physiol. 1985 Mar; 248(3 Pt 1):E375-80.
    View in: PubMed
    Score: 0.003
  80. Draznin B, Mehler PS, Leitner JW, Sussman KE, Dahl R, Vatter A, Melmed S. Localization of somatostatin receptors in secretion vesicles in anterior pituitary cells and pancreatic islets. J Recept Res. 1985; 5(1):83-103.
    View in: PubMed
    Score: 0.003
  81. Draznin B, Trowbridge M, Ferguson L. Quantitative studies of the rate of insulin internalization in isolated rat hepatocytes. Biochem J. 1984 Mar 01; 218(2):307-12.
    View in: PubMed
    Score: 0.003
  82. Trowbridge M, Draznin B. Effect of fasting on insulin's ability to inhibit intracellular proteolysis. Horm Metab Res. 1983 Jan; 15(1):48-9.
    View in: PubMed
    Score: 0.003
  83. Rifkin RM, Todd WW, Toothaker DR, Sussman A, Trowbridge M, Draznin B. Effects of in vivo and in vitro alcohol administration on insulin binding and glycogenesis in isolated rat hepatocytes. Ann Nutr Metab. 1983; 27(4):313-9.
    View in: PubMed
    Score: 0.003
  84. Sussman KE, Mehler PS, Leitner JW, Draznin B. Role of the secretion vesicle in the transport of receptors: modulation of somatostatin binding to pancreatic islets. Endocrinology. 1982 Jul; 111(1):316-23.
    View in: PubMed
    Score: 0.003
  85. Draznin B, Leitner JW, Sussman KE. Kinetics of somatostatin receptor migration in isolated pancreatic islets. Diabetes. 1982 May; 31(5 Pt 1):467-9.
    View in: PubMed
    Score: 0.003
  86. Barbour LA, Shao J, Qiao L, Pulawa LK, Jensen DR, Bartke A, Garrity M, Draznin B, Friedman JE. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol. 2002 Mar; 186(3):512-7.
    View in: PubMed
    Score: 0.003
  87. Shao J, Yamashita H, Qiao L, Draznin B, Friedman JE. Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes. 2002 Jan; 51(1):19-29.
    View in: PubMed
    Score: 0.003
  88. Miller LL, Schalch DS, Draznin B. Role of the liver in regulating somatomedin activity: effects of streptozotocin diabetes and starvation on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology. 1981 Apr; 108(4):1265-71.
    View in: PubMed
    Score: 0.003
  89. Draznin B, Todd WW, Leitner JW, Toothaker DR. Lysosomal and non-lysosomal pathways of intracellular insulin degradation in isolated rat hepatocytes. Horm Res. 1981; 15(4):252-62.
    View in: PubMed
    Score: 0.003
  90. Draznin B, Solomons CC, Toothaker DR, Sussman KE. Energy-dependent steps in insulin-hepatocyte interaction. Endocrinology. 1981 Jan; 108(1):8-17.
    View in: PubMed
    Score: 0.003
  91. Draznin B, Solomons CC, Emler CA, Schalch DS, Sussman KE. Decreased insulin binding and degradation associated with depressed intracellular ATP content. Diabetes. 1980 Mar; 29(3):221-6.
    View in: PubMed
    Score: 0.002
  92. Sasaoka T, Langlois WJ, Bai F, Rose DW, Leitner JW, Decker SJ, Saltiel A, Gill GN, Kobayashi M, Draznin B, Olefsky JM. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites. J Biol Chem. 1996 Apr 05; 271(14):8338-44.
    View in: PubMed
    Score: 0.002
  93. Jhun BH, Haruta T, Meinkoth JL, Leitner W, Draznin B, Saltiel AR, Pang L, Sasaoka T, Olefsky JM. Signal transduction pathways leading to insulin-induced early gene induction. Biochemistry. 1995 Jun 27; 34(25):7996-8004.
    View in: PubMed
    Score: 0.002
  94. Sasaoka T, Langlois WJ, Leitner JW, Draznin B, Olefsky JM. The signaling pathway coupling epidermal growth factor receptors to activation of p21ras. J Biol Chem. 1994 Dec 23; 269(51):32621-5.
    View in: PubMed
    Score: 0.002
  95. Robinson LJ, Leitner W, Draznin B, Heidenreich KA. Evidence that p21ras mediates the neurotrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons. Endocrinology. 1994 Dec; 135(6):2568-73.
    View in: PubMed
    Score: 0.002
  96. Sasaoka T, Rose DW, Jhun BH, Saltiel AR, Draznin B, Olefsky JM. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem. 1994 May 06; 269(18):13689-94.
    View in: PubMed
    Score: 0.002
  97. Sasaoka T, Draznin B, Leitner JW, Langlois WJ, Olefsky JM. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J Biol Chem. 1994 Apr 08; 269(14):10734-8.
    View in: PubMed
    Score: 0.002
  98. Jhun BH, Meinkoth JL, Leitner JW, Draznin B, Olefsky JM. Insulin and insulin-like growth factor-I signal transduction requires p21ras. J Biol Chem. 1994 Feb 25; 269(8):5699-704.
    View in: PubMed
    Score: 0.002
  99. Begum N, Robinson LJ, Draznin B, Heidenreich KA. Protein phosphatase-1 and -2a activities in cultured fetal chick neurons: differential regulation by insulin and insulin-like growth factor-I. Endocrinology. 1993 Nov; 133(5):2085-90.
    View in: PubMed
    Score: 0.002
  100. Metz SA, Draznin B, Sussman KE, Leitner JW. Unmasking of arachidonate-induced insulin release by removal of extracellular calcium. Arachidonic acid mobilizes cellular calcium in rat islets of Langerhans. Biochem Biophys Res Commun. 1987 Jan 15; 142(1):251-8.
    View in: PubMed
    Score: 0.001
  101. Steinberg JP, Leitner JW, Draznin B, Sussman KE. Calmodulin and cyclic AMP. Possible different sites of action of these two regulatory agents in exocytotic hormone release. Diabetes. 1984 Apr; 33(4):339-45.
    View in: PubMed
    Score: 0.001
  102. Trowbridge M, Sussman A, Ferguson L, Draznin B, Neufeld N, Begum N, Tepperman H, Tepperman J. Mechanisms of the fasting-induced dissociation of insulin binding from its action in isolated rat hepatocytes. Mol Cell Biochem. 1984 Apr; 62(1):25-36.
    View in: PubMed
    Score: 0.001
  103. Sussman KE, Draznin B, Leitner JW, Mehler PS. The endocrine secretion granule revisited- postulating new functions. Metabolism. 1982 Sep; 31(9):959-67.
    View in: PubMed
    Score: 0.001
  104. Schalch DS, Burstein PJ, Tewel SJ, Draznin B, Emler CA. The effect of renal impairment on growth in the rat: relationship to malnutrition and serum somatomedin levels. Endocrinology. 1981 May; 108(5):1683-9.
    View in: PubMed
    Score: 0.001
  105. Burstein PJ, Draznin B, Johnson CJ, Schalch DS. The effect of hypothyroidism on growth, serum growth hormone, the growth hormone-dependent somatomedin, insulin-like growth factor, and its carrier protein in rats. Endocrinology. 1979 Apr; 104(4):1107-11.
    View in: PubMed
    Score: 0.001
  106. Schalch DS, Heinrich UE, Draznin B, Johnson CJ, Miller LL. Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology. 1979 Apr; 104(4):1143-51.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)